Developing a Case-Based Blended Learning Ecosystem to Optimize Precision Medicine: Reducing Overdiagnosis and Overtreatment

Introduction: Precision medicine aims to focus on meeting patient requirements accurately, optimizing patient outcomes, and reducing under-/overdiagnosis and therapy. We aim to offer a fresh perspective on accuracy driven “age-old precision medicine” and illustrate how newer case-based blended learning ecosystems (CBBLE) can strengthen the bridge between age-old precision approaches with modern technology and omics-driven approaches. Methodology: We present a series of cases and examine the role of precision medicine within a “case-based blended learning ecosystem” (CBBLE) as a practicable tool to reduce overdiagnosis and overtreatment. We illustrated the workflow of our CBBLE through case-based narratives from global students of CBBLE in high and low resource settings as is reflected in global health. Results: Four micro-narratives based on collective past experiences were generated to explain concepts of age-old patient-centered scientific accuracy and precision and four macro-narratives were collected from individual learners in our CBBLE. Insights gathered from a critical appraisal and thematic analysis of the narratives were discussed. Discussion and conclusion: Case-based narratives from the individual learners in our CBBLE amply illustrate their journeys beginning with “age-old precision thinking” in low-resource settings and progressing to “omics-driven” high-resource precision medicine setups to demonstrate how the approaches, used judiciously, might reduce the current pandemic of over-/underdiagnosis and over-/undertreatment.

[1]  J. Gartner,et al.  Immune recognition of somatic mutations leading to complete durable regression in metastatic breast cancer , 2018, Nature Medicine.

[2]  Nicolas Servant,et al.  Molecularly targeted therapy based on tumour molecular profiling versus conventional therapy for advanced cancer (SHIVA): a multicentre, open-label, proof-of-concept, randomised, controlled phase 2 trial. , 2015, The Lancet. Oncology.

[3]  J. T. McGautry,et al.  Medical education. , 1978, Cutis.

[4]  G. Dy,et al.  Alterations in genes other than EGFR/ALK/ROS1 in non-small cell lung cancer: trials and treatment options , 2016, Cancer biology & medicine.

[5]  Joachim P. Sturmberg,et al.  The User Driven Learning Environment , 2013 .

[6]  Alessandro Testori,et al.  The role of BRAF V600 mutation in melanoma , 2012, Journal of Translational Medicine.

[7]  A. Chen,et al.  An overview of the NCI precision medicine trials-NCI MATCH and MPACT. , 2015, Chinese clinical oncology.

[8]  B. Djulbegovic,et al.  Evidence-based medicine meets person-centred care: a collaborative perspective on the relationship. , 2015, Journal of evaluation in clinical practice.

[9]  E. Lindsay Thrombectomy 6 to 24 Hours after Stroke with a Mismatch between Deficit and Infarct , 2018 .

[10]  Carmel M. Martin,et al.  User-Driven Healthcare and Narrative Medicine: Utilizing Collaborative Social Networks and Technologies , 2010 .

[11]  Richard L Kravitz,et al.  Harnessing experience: exploring the gap between evidence-based medicine and clinical practice. , 2008, Journal of evaluation in clinical practice.

[12]  R. Raz Urinary Tract Infection in Postmenopausal Women , 2011, Korean journal of urology.

[13]  Stefan V. Pantazi,et al.  Case-based medical informatics , 2004, BMC Medical Informatics Decis. Mak..

[14]  Lisa M Behnke,et al.  A targeted approach to reducing overutilization: use of percutaneous coronary intervention in stable coronary artery disease. , 2013, Population health management.

[15]  Sudhir Srivastava,et al.  Addressing overdiagnosis and overtreatment in cancer: a prescription for change. , 2014, The Lancet. Oncology.

[16]  K. Patel,et al.  Detection of Circulating Thyroid Tumor DNA in Patients with Thyroid Nodules , 2015 .

[17]  Pascal Pommier,et al.  Optimizing clinical practice with case-based reasoning approach. , 2008, Journal of evaluation in clinical practice.

[18]  P. A.,et al.  comparative effectiveness research collaboration and precision medicine , 2015, Annals of neurosciences.

[19]  R. Biswas,et al.  Understanding Clinical Complexity Through Conversational Learning in Medical Social Networks: Implementing User-Driven Health Care , 2013 .

[20]  Igor Jurisica,et al.  Case-Based Reasoning for Biomedical Informatics and Medicine , 2014 .

[21]  M. Amiot,et al.  Efficacy of venetoclax as targeted therapy for relapsed/refractory t(11;14) multiple myeloma. , 2017, Blood.

[22]  T. Fleming,et al.  Use of chemotherapy plus a monoclonal antibody against HER2 for metastatic breast cancer that overexpresses HER2. , 2001, The New England journal of medicine.

[23]  A. Hackshaw,et al.  Randomized Prospective Biomarker Trial of ERCC1 for Comparing Platinum and Nonplatinum Therapy in Advanced Non-Small-Cell Lung Cancer: ERCC1 Trial (ET). , 2017, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[24]  P. Kerkar,et al.  Appropriateness of elective percutaneous coronary intervention and impact of government health insurance scheme — A tertiary centre experience from Western India , 2017, Indian heart journal.

[25]  G. Dy,et al.  Alterations in genes other than EGFR/ALK/ROS1 in non-small cell lung cancer: trials and treatment options@@@Alterations in genes other than EGFR/ALK/ROS1 in non-small cell lung cancer: trials and treatment options , 2016 .

[26]  S. Saeed,et al.  Comparison of Fine Needle Aspiration Cytology and Thyroid Scan in Solitary Thyroid Nodule , 2011, Pathology research international.

[27]  S. Brownlee,et al.  Evidence for overuse of medical services around the world , 2017, The Lancet.

[28]  Prescription audit for evaluation of present prescribing trends in a rural tertiary care hospital in South India: an observational study - , 2016 .

[29]  L. Klotz,et al.  Cancer overdiagnosis and overtreatment , 2012, Current opinion in urology.

[30]  P R Shankar,et al.  Initiating and strengthening medical student research: time to take up the gauntlet. , 2006, Kathmandu University medical journal.

[31]  F. Scheele,et al.  Innovator’s prescription , 2015 .

[32]  A. D. Van den Abbeele,et al.  Efficacy and safety of imatinib mesylate in advanced gastrointestinal stromal tumors. , 2002, The New England journal of medicine.

[33]  Jai Ganesh Udayasankaran,et al.  From Dyadic Ties to Information Infrastructures: Care-Coordination between Patients, Providers, Students and Researchers , 2015, Yearbook of Medical Informatics.

[34]  R. Herbst,et al.  Quantitative Assessment of the Heterogeneity of PD-L1 Expression in Non-Small-Cell Lung Cancer. , 2016, JAMA oncology.

[35]  Martin C. Müller,et al.  Impact of comorbidities on overall survival in patients with chronic myeloid leukemia: results of the randomized CML study IV. , 2015, Blood.

[36]  David J Hunter,et al.  Uncertainty in the Era of Precision Medicine. , 2016, The New England journal of medicine.

[37]  L. Klotz,et al.  Overtreatment in cancer – is it a problem? , 2016, Expert opinion on pharmacotherapy.

[38]  Amy Price,et al.  Medical Students Meet User Driven Health Care for Patient Centered Learning in Clinical Medicine , 2014 .

[39]  R. Biswas,et al.  Person-centered healthcare in the information age: Experiences from a user driven healthcare network , 2013 .

[40]  F. Collins,et al.  A new initiative on precision medicine. , 2015, The New England journal of medicine.